Study uses base editing to correct mutation that causes rare immune deficiency

A new UCLA-led study suggests that advanced genome editing technology could be used as a one-time treatment for the rare and deadly genetic disease CD3 delta severe combined immunodeficiency.

Leave A Comment

Your email address will not be published. Required fields are marked *